Differential effects of leptin on adiponectin expression with weight gain versus obesity.

PubWeight™: 0.81‹?›

🔗 View Article (PMID 26374448)

Published in Int J Obes (Lond) on September 16, 2015

Authors

P Singh1, P Sharma1, K R Sahakyan1, D E Davison1, F H Sert-Kuniyoshi1, A Romero-Corral1,2, J M Swain3,4, M D Jensen5, F Lopez-Jimenez1, T Kara1,6, V K Somers1

Author Affiliations

1: Division of Cardiovascular Disease, Mayo Clinic, Rochester, MN, USA.
2: Division of Cardiology, Einstein Medical Center, Philadelphia, PA, USA.
3: Department of Surgery, Mayo Clinic, Rochester, MN, USA.
4: Scottsdale Healthcare Bariatric Center, University of Arizona College of Medicine, Phoenix, AZ, USA.
5: Endocrinology Research Unit, Mayo Clinic, Rochester, MN, USA.
6: ICRC-Department of Cardiovascular Diseases, St. Anne's University Hospital Brno, Brno, Czech Republic.

Articles cited by this

Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun (1999) 14.25

Obesity and insulin resistance. J Clin Invest (2000) 10.47

A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem (1995) 9.72

Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest (2006) 9.49

AdipoQ is a novel adipose-specific gene dysregulated in obesity. J Biol Chem (1996) 6.93

Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia (2003) 5.91

Caveolin-1-deficient mice are lean, resistant to diet-induced obesity, and show hypertriglyceridemia with adipocyte abnormalities. J Biol Chem (2001) 3.54

STAT3 serine phosphorylation by ERK-dependent and -independent pathways negatively modulates its tyrosine phosphorylation. Mol Cell Biol (1997) 3.18

Leptin resistance: a possible interface of inflammation and metabolism in obesity-related cardiovascular disease. J Am Coll Cardiol (2008) 2.42

Phenotypic effects of leptin replacement on morbid obesity, diabetes mellitus, hypogonadism, and behavior in leptin-deficient adults. Proc Natl Acad Sci U S A (2004) 2.41

Inverse relationship between plasma adiponectin and leptin concentrations in normal-weight and obese women. Eur J Endocrinol (2002) 2.06

Leptin in human physiology and pathophysiology. Am J Physiol Endocrinol Metab (2011) 1.99

Adiponectin in health and disease: evaluation of adiponectin-targeted drug development strategies. Trends Pharmacol Sci (2009) 1.89

Correlation of the leptin:adiponectin ratio with measures of insulin resistance in non-diabetic individuals. Diabetologia (2009) 1.81

Serum adiponectin and leptin levels in patients with lipodystrophies. J Clin Endocrinol Metab (2002) 1.78

High adiponectin concentrations are associated with the metabolically healthy obese phenotype. J Clin Endocrinol Metab (2008) 1.76

Insulin and leptin revisited: adiposity signals with overlapping physiological and intracellular signaling capabilities. Front Neuroendocrinol (2003) 1.74

Leptin antagonist reverses hypertension caused by leptin overexpression, but fails to normalize obesity-related hypertension. J Hypertens (2007) 1.63

Interferon gamma attenuates insulin signaling, lipid storage, and differentiation in human adipocytes via activation of the JAK/STAT pathway. J Biol Chem (2009) 1.60

Transcriptional and post-translational regulation of adiponectin. Biochem J (2009) 1.52

Impact of short-term high-fat feeding on glucose and insulin metabolism in young healthy men. J Physiol (2009) 1.52

Plasma adiponectin and leptin levels, body composition, and glucose utilization in adult women with wide ranges of age and obesity. Diabetes Care (2003) 1.37

Altered mitochondrial function and metabolic inflexibility associated with loss of caveolin-1. Cell Metab (2012) 1.35

Leptin antagonist reveals that the normalization of caloric intake and the thermic effect of food after high-fat feeding are leptin dependent. Am J Physiol Regul Integr Comp Physiol (2006) 1.31

Selective insulin and leptin resistance in metabolic disorders. Cell Metab (2012) 1.25

Development and characterization of high affinity leptins and leptin antagonists. J Biol Chem (2010) 1.24

Selective leptin resistance revisited. Am J Physiol Regul Integr Comp Physiol (2013) 1.21

Short-term overfeeding may induce peripheral insulin resistance without altering subcutaneous adipose tissue macrophages in humans. Diabetes (2010) 1.21

Adipose tissue gene expression profiles in ob/ob mice treated with leptin. Life Sci (2008) 1.20

Subcutaneous adipose tissue remodeling during the initial phase of weight gain induced by overfeeding in humans. J Clin Endocrinol Metab (2011) 1.17

Adipocyte-selective reduction of the leptin receptors induced by antisense RNA leads to increased adiposity, dyslipidemia, and insulin resistance. J Biol Chem (2003) 1.12

Relationship between the adiponectin-leptin ratio and parameters of insulin resistance in subjects without hyperglycemia. Metabolism (2006) 1.08

Modest visceral fat gain causes endothelial dysfunction in healthy humans. J Am Coll Cardiol (2010) 1.04

High leptin/adiponectin ratio and serum triglycerides are associated with an "at-risk" phenotype in young severely obese patients. Obesity (Silver Spring) (2010) 1.04

Pro-inflammatory delipidizing cytokines reduce adiponectin secretion from human adipocytes without affecting adiponectin oligomerization. J Endocrinol (2007) 1.03

Weight gain reveals dramatic increases in skeletal muscle extracellular matrix remodeling. J Clin Endocrinol Metab (2014) 1.02

Biphasic regulation of extracellular-signal-regulated protein kinase by leptin in macrophages: role in regulating STAT3 Ser727 phosphorylation and DNA binding. Biochem J (2002) 1.02

Extracellular signal-regulated protein kinase (ERK)-dependent and ERK-independent pathways target STAT3 on serine-727 in human neutrophils stimulated by chemotactic factors and cytokines. Biochem J (1999) 1.02

The MEK-ERK pathway is necessary for serine phosphorylation of mitochondrial STAT3 and Ras-mediated transformation. PLoS One (2013) 0.99

Melanocortin potentiates leptin-induced STAT3 signaling via MAPK pathway. J Neurochem (2009) 0.97

Leptin treatment markedly increased plasma adiponectin but barely decreased plasma resistin of ob/ob mice. Am J Physiol Endocrinol Metab (2004) 0.94

Adiponectin is stimulated by adrenalectomy in ob/ob mice and is highly correlated with resistin mRNA. Am J Physiol Endocrinol Metab (2002) 0.94

Regulation of adiponectin production by insulin: interactions with tumor necrosis factor-α and interleukin-6. Am J Physiol Endocrinol Metab (2010) 0.94

Effects of weight gain and weight loss on regional fat distribution. Am J Clin Nutr (2012) 0.91

Weight gain by hyperalimentation elevates C-reactive protein levels but does not affect circulating levels of adiponectin or resistin in healthy subjects. Eur J Endocrinol (2010) 0.89

Impact of simvastatin on adipose tissue: pleiotropic effects in vivo. Endocrinology (2009) 0.86

Short-term overfeeding increases circulating adiponectin independent of obesity status. PLoS One (2013) 0.85

Leptin signaling in adipose tissue: role in lipid accumulation and weight gain. Circ Res (2012) 0.84

FTO contributes to hepatic metabolism regulation through regulation of leptin action and STAT3 signalling in liver. Cell Commun Signal (2014) 0.82

Effect of weight gain on cardiac autonomic control during wakefulness and sleep. Hypertension (2011) 0.82

Adiponectin concentration and insulin indicators following overfeeding in identical twins. J Endocrinol Invest (2008) 0.80

Leptin differentially regulate STAT3 activation in ob/ob mouse adipose mesenchymal stem cells. Nutr Metab (Lond) (2012) 0.80

Metabolically protective cytokines adiponectin and fibroblast growth factor-21 are increased by acute overfeeding in healthy humans. PLoS One (2013) 0.80

The Sir David Cuthbertson Medal Lecture. Hunting for new pieces to the complex puzzle of obesity. Proc Nutr Soc (2006) 0.79